Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of...
23 insider purchases on record · latest filing 2022-06-21.
Insiders have also filed 46 sale transactions at VAXX.